Ghrelin's second life - World Journal of Gastroenterology

More documents

Recommendations

Info

CCl4/YGJ CCl4-13 wk CCl4-7 wk Control EGFP α-SMA Merge Figure 4 Immunofluorescent colocalization of enhanced green fluorescent protein and α-smooth muscle actin in CCl4-induced chronic liver injury in bone marrow chimera mice, × 200. EGFP is shown in green and α-smooth muscle actin (α-SMA) in red. A yellow color confirms colocalization in the merged images. The number of EGFP/α-SMA double positive cells was found to increase in all mice after receiving CCl4 injection and they were mainly found in the areas of scarring. In contrast, the number of EGFP + /α-SMA + cells decreased in the YGJ treatment group. EGFP: Enhanced green fluorescent protein; YGJ: Yiguanjian. found in the areas of scarring. However, YGJ treatment significantly decreased the number of EGFP + /αSMA + WJG|www.wjgnet.com Wang XL et al . YGJ decoction protects against hepatic injury 3241 July 7, 2012|Volume 18|Issue 25|
CCl4/YGJ CCl4-13 wk CCl4-7 wk Control Wang XL et al . YGJ decoction protects against hepatic injury EGFP Alb Merge Figure 5 Immunofluorescent colocalization of enhanced green fluorescent protein and albumin in CCl4-induced chronic liver injured bone marrow chimera mice, × 200. EGFP is shown in green and Alb in red. No yellow color is visible in the merged images in control, CCl4 or CCl4 + YGJ groups. EGFP: Enhanced green fluorescent protein; YGJ: Yiguanjian; Alb: Albumin. cells as compared with the CCl4-injected controls at the same timepoints (P < 0.01) (Figure 4). WJG|www.wjgnet.com Because of the apparent increase in the number of EGFP + cells in parenchymal areas in YGJtreated mice 3242 July 7, 2012|Volume 18|Issue 25|
Page 1 and 2:
World Journal of Gastroenterology W
Page 3 and 4:
Phillip S Oates, Perth Ross C Smith
Page 5 and 6:
Deepak N Amarapurkar, Mumbai Abhiji
Page 7 and 8:
Trine Olsen, Tromsø Eyvind J Pauls
Page 9 and 10:
Conor P Delaney, Cleveland Sharon D
Page 11 and 12:
S Contents EDITORIAL TOPIC HIGHLIGH
Page 13 and 14:
Contents ACKNOWLEDGMENTS APPENDIX A
Page 15 and 16:
Verhulst PJ et al . Ghrelin and glu
Page 17 and 18:
Page 19 and 20:
Page 21 and 22: Verhulst PJ et al . Ghrelin and glu
Page 27: Online Submissions: http://www.wjgn
Page 31: Ishikawa T. Zinc during interferon
Page 35 and 36: Sitarz R et al . Gastroenterostoma
Page 37 and 38: Sitarz R et al . Gastroenterostoma
Page 39 and 40: Morais TC et al . Gastrointestinal
Page 47 and 48: Song MJ et al . Usefulness of PET/C
Page 49 and 50: A Sensitivity B Sensitivity C Sensi
Page 55 and 56: Bae GS et al . Anti-inflammatory ef
Page 59 and 60: B Myeloperoxidase activity (U/mg pr
Page 61 and 62: A Time (h) - 1 3 6 NJ4 B Relative H
Page 63 and 64: A C Time (h) - 1 3 6 NJ4-2 B Relati
Page 70 and 71: A Collagen staining (fold change) C
Page 74 and 75: CCl4/YGJ CCl4-13 wk CCl4-7 wk Contr
Page 76 and 77: liver and have potent proliferative
Page 78 and 79: A 8 wk 9 wk 10 wk 13 wk CCl4/YGJ CC
Page 80 and 81: Cheng JC. A Chinese Herbal Decoctio
Page 82 and 83: Singh R, Neo EN, Nordeen N, Shanmug
Page 84 and 85: etter patient tolerance with regard
Page 86: Key words: Intestinal alkaline phos
Page 89 and 90: Molnár K et al . iAP in pediatric
Page 97 and 98: Chung WC et al . Ulcer after gastre
Page 99: Yang HY et al . Early resection of
Page 102 and 103: indicate a later timing for radical
Page 104 and 105: Zhao WC, Zhang HB, Yang N, Fu Y, Qi
Page 106 and 107: level, or rapid enlargement of lesi
Page 108 and 109: Table 3 Area under the receiver ope
Page 111 and 112: Zhao WC et al . Prognostic factors
Page 113 and 114: Online Submissions: http://www.wjgn
Page 116 and 117: mV 0 2 4 6 8 cpm FD patients are sh
Page 118 and 119: COMMENTS Background Gastric motilit
Page 120 and 121: thirds partial hepatectomy (PH) in
Page 122:
A Serum ALT (U/L) C Serum alkaline
Page 126 and 127:
REFERENCES 1 Schibler U. Circadian
Page 132 and 133:
positive patients were found to hav
Page 134:
Online Submissions: http://www.wjgn
Page 140:
21 Tosolini M, Kirilovsky A, Mlecni
Page 147 and 148:
Diao TJ et al . NO and hepatopulmon
Page 149 and 150:
Gallegos M et al . Lymphogranuloma
Page 151 and 152:
Gallegos M et al . Lymphogranuloma
Page 153 and 154:
Page 155 and 156:
A Hadžić N et al . Diagnosis in B
Page 157 and 158:
Hadžić N et al . Diagnosis in BAA
Page 159 and 160:
A B Chung HJ et al . Choledocholith
Page 161 and 162:
Chung HJ et al . Choledocholithiasi
Page 163 and 164:
Page 165 and 166:
Instructions to authors ISSN and EI
Page 167 and 168:
Instructions to authors AIM (no mor
Page 169 and 170:
Instructions to authors Guidelines
show all

Ghrelin's second life - World Journal of Gastroenterology

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?